Triple Strength Lecithin Phosphatidyl Choline 420 mg Ingredients & Drug Interactions
What is this page for?
First and foremost: checking Triple Strength Lecithin Phosphatidyl Choline 420 mg against your medications. The heart of this page is the interaction checker and the full interaction report — how this product’s ingredients may interact with prescription and over-the-counter medicines you may be taking.
Around that, we add a pharmacist’s high-level view of the product as a whole — what’s inside, the evidence for its stated use, how transparent the label is, and what safety data exists — so you can see the full picture in one place. It’s educational information from our licensed clinical databases and the clinical staff at HelloPharmacist — not medical advice — and we don’t sell or endorse products. Our editorial policy
Triple Strength Lecithin Phosphatidyl Choline 420 mg is a dietary supplement by Wonder Laboratories with 4 active ingredients. Its ingredients are commonly taken for liver health, memory and brain support, ulcerative colitis.We don’t currently list a known drug interaction for its mapped ingredients — but that doesn’t guarantee none exist, so always confirm with your pharmacist.
HelloPharmacist Scorecard of Triple Strength Lecithin Phosphatidyl Choline 420 mg by Wonder Laboratories
Our pharmacy team’s full take, with four database checks built into the cards below — a summary of what is known, not a grade of the product itself.
What’s inside
Full disclosure
This softgel contains 4 active ingredients: two forms of phospholipids — Soy Lecithin Concentrate and Phosphatidylcholine — plus two fatty acids, Linoleic Acid and Linolenic Acid. The softgel itself is made from gelatin and glycerin.
Soy Lecithin Concentrate and Phosphatidylcholine are the main components; they're both compounds found naturally in foods and are involved in cell membrane structure and brain function.
Does it work?
Not established
The evidence for this product is mixed and often inconclusive. Phosphatidylcholine shows possibly effective evidence for ulcerative colitis (inflammatory bowel disease), but for other conditions — including Alzheimer disease, anxiety, and nonalcoholic fatty liver disease — the evidence is insufficient to establish whether it works.
Soy Lecithin Concentrate, meanwhile, is rated likely ineffective for Alzheimer disease and has insufficient evidence for age-related cognitive decline, anxiety, and bipolar disorder. If you're considering this for a specific health goal, talk with your pharmacist about whether the evidence supports that use.
How safe is it?
Well-documented data
Both main ingredients are generally well tolerated orally. The most common side effects are digestive: abdominal pain, diarrhea, bloating, nausea, and fullness.
At high doses — especially 30 grams or more of phosphatidylcholine daily — digestive upset becomes more likely. If you have an egg or soy allergy, be aware that lecithin can trigger allergic skin reactions in sensitive people.
For pregnancy, Soy Lecithin Concentrate is rated likely safe; Phosphatidylcholine has insufficient data on supplement safety beyond normal food amounts, so check with your doctor. Breastfeeding safety for Phosphatidylcholine is not well studied in supplement form — talk with your healthcare provider first.
Meds to double-check
No known interactions
No interactions are documented in our data for the ingredients we could check. We could not check Linoleic Acid or Linolenic Acid, so verify your medications on this page's checker before you start just to be thorough.
The bottom line
Scorecard at a glanceFully disclosed formula with no established evidence rating for its marketed use. No medication interactions are currently documented, and safety information is well characterized.
This product is generally well tolerated and may be worth trying if you're interested in phospholipid support — just know the evidence for most conditions is thin. If digestive upset happens, it's likely mild and temporary.
Anyone with a soy or egg allergy should avoid it, and if you're pregnant or breastfeeding, run it by your doctor or pharmacist first.
Educational only — not medical advice; always confirm with your pharmacist. Our editorial policy · How we use AI
Assessment coverage: 2 of 4 active ingredients matched to our full ingredient reviews (monographs). Based on the product label dated Aug 22, 2024.
This Scorecard evaluates available label information, ingredient evidence, and known medication-safety considerations. It does not independently verify product identity, purity, potency, contamination, or manufacturing quality. How these ratings are computed
General information
Key facts about Triple Strength Lecithin Phosphatidyl Choline 420 mg, straight from the product label.
| Brand | Wonder Laboratories |
|---|---|
| Barcode (UPC) | 099528280032 |
| Net contents | 300 Softgel(s) |
| Market status | On market |
| Date entered into DSLD | Aug 22, 2024 |
| DSLD ID | 315432 |
| Product type | Fat/fatty Acid |
| Supplement form | Softgel Capsule |
| Dietary claims / uses | All Other, Structure/Function |
| Intended target group(s) | Adult (18 - 50 Years), Gluten Free |
Everything in this section is reproduced from the manufacturer’s own product label — it’s the label speaking, not HelloPharmacist. We show it so you can see exactly what the maker states; we don’t verify or endorse those statements.
Supplement Facts
The label details for Triple Strength Lecithin Phosphatidyl Choline 420 mg by Wonder Laboratories, sourced from the NIH Dietary Supplement Label Database.
Supplement Facts
| Ingredient | Amount | % DV |
|---|---|---|
| Calories | 10 Calorie(s) | -- |
| Calories from Fat | 10 Calorie(s) | -- |
| Total Fat | 1 Gram(s) | 1% |
| Linoleic Acid | 384 mg | -- |
| Soy Lecithin Concentrate | 1200 mg | -- |
| Phosphatidylcholine | 420 mg | -- |
| Linolenic Acid | 48 mg | -- |
| Phosphatidylinositol | 15 mg | -- |
Other ingredients: Gelatin, Glycerin
Tap any ingredient to jump to its full detail below.
These statements are the manufacturer’s wording, reproduced from the product label — the label is saying it, not HelloPharmacist. We don’t verify or endorse them.
Formula
Soybean phosphatide complex, containing a minimum of 35% (420 mg) of important phosphatidyl choline, which is equivalent to 65 mg of natural choline with other naturally occurring components such as cephalin (phosphatidyl ethanolamine), inositol phosphatides (phosphoinositides) and related phosphorus containing lipids enclosed with gelatin to ensure freshness and potency. Formula 280 provides 3 times more choline than a regular 1200 mg lecithin softgel.
Choline is important for normal cellular membrane composition and repair, normal brain, cardiovascular and liver function.
Precautions
Tamper evident: Do not use this product if imprinted foil seal under cap is broken or missing.
Keep out of reach of children.
Caution: If you are pregnant or nursing, consult your physician before taking this product.
Contains soy ingredients.
Storage
Keep tightly closed. Store at room temperature: 59 degrees - 86 degrees F (15 degrees to 30 degrees C).
Formulation
Mfg. in an FDA Registered Facility using Good Manufacturing Practices (GMPs)
Gluten free
Conforms to USP <2091> for weight. Meets USP <2040> disintegration for maximum bioavailability.
Made in USA
FDA Disclaimer Statement
This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
General Statements
Formula 280
FDA Statement of Identity
Dietary Supplement
Suggested/Recommended/Usage/Directions
Directions: As a dietary supplement, take 1 softgel twice daily.
Is this label outdated? Report a formula or label change and our pharmacy team will review it.
Triple Strength Lecithin Phosphatidyl Choline 420 mg by Wonder Laboratories label
The label scan from the NIH Dietary Supplement Label Database. Tap to enlarge.
Label images are published by the NIH Dietary Supplement Label Database for the version of this product on file. Always read your actual product label.
View the full label (PDF)The Ingredients in Triple Strength Lecithin Phosphatidyl Choline 420 mg by Wonder Laboratories
These are the 4 active ingredients this product is made of. Select any to open its full monograph.
Serving size1 Softgel(s) Dosage formSoftgel Capsule Servings per container300 Amounts shown are per serving.
Most supplement products combine several ingredients, and a medication can interact with the product through any one of them. Each ingredient below shows whether it has known drug interactions.
Linoleic Acid
Phosphatidylcholine
No knowninteractions
Phosphatidylcholine is a phospholipid that is part of every cell membrane and a source of choline. People take it for liver, brain, and gut health, bu...
Phosphatidylcholine monograph & interactionsLinolenic Acid
Phosphatidylinositol
Other (inactive) ingredients: Gelatin, Glycerin. These complete the product’s ingredient list but are not active constituents.
Triple Strength Lecithin Phosphatidyl Choline 420 mg by Wonder Laboratories Drug Interactions
We don’t currently list any known drug interactions for the mapped ingredients in Triple Strength Lecithin Phosphatidyl Choline 420 mg. This doesn’t guarantee none exist — always confirm with your pharmacist before combining a supplement with your medications.
Brand information
Manufacturer and brand details for Triple Strength Lecithin Phosphatidyl Choline 420 mg, from the product label.
Wonder Laboratories
See all Wonder Laboratories products- Name
- Wonder Laboratories
- Street Address
- 115 S.C.T. Ct.
- City
- White House
- State
- TN
- ZipCode
- 37188
Triple Strength Lecithin Phosphatidyl Choline 420 mg by Wonder Laboratories: Common Questions
Does Triple Strength Lecithin Phosphatidyl Choline 420 mg by Wonder Laboratories interact with any medications?
How can one product interact with so many drugs?
Where does this information come from?
Will this help my memory or Alzheimer's disease?
What are the most common side effects?
Can I take this if I'm pregnant or breastfeeding?
Is this safe if I have a soy allergy?
What exactly are phospholipids and why are they in this?
Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy
Not sure if Triple Strength Lecithin Phosphatidyl Choline 420 mg is safe with your meds?
Our pharmacists answer your medication & supplement questions — free.
Label information is sourced from the NIH Dietary Supplement Label Database and reflects the product version on file; always read your actual product label. This page is for education only and is not a substitute for professional medical advice. Confirm with your pharmacist or doctor before combining supplements and medications.
The Full Monographs Behind Triple Strength Lecithin Phosphatidyl Choline 420 mg’s Ingredients
Every ingredient we hold a full HelloPharmacist monograph for — uses, evidence, safety, and the complete interaction list.
Phosphatidylcholine
Phosphatidylcholine is a phospholipid that is part of every cell membrane and a source of choline. People take it for liver, brain, and gut health, but solid human evidence is limited for mo...
Read the full Phosphatidylcholine monograph → Herb & supplement monographLecithin
Lecithin is a natural fatty substance found in foods and made by the body that is widely used as a supplement and food emulsifier. Evidence supporting most of its health claims is limited, t...
Read the full Lecithin monograph →Sources & How We Checked
Triple Strength Lecithin Phosphatidyl Choline 420 mg's label data comes from the NIH Dietary Supplement Label Database; the ingredient interaction data is from the Natural Medicines database, reviewed by our pharmacists.
- NIH Dietary Supplement Label Database (DSLD) — The official product label on file for this supplement.
- Natural Medicines (Therapeutic Research Center) — Evidence-graded clinical reference behind the ingredient interaction data.
Content is written and reviewed by licensed HelloPharmacist pharmacists. See our data sources and editorial standards for how this information is built and checked.
The 24 references behind this product’s interaction data
Every citation that drives the interaction findings for this product’s ingredients, from the evidence-graded Natural Medicines (TRC Healthcare) database. Open an ingredient to browse its citations — links open the study on PubMed or the publisher’s site.
Lecithin 9 references
- Buchman AL, Dubin M, Jenden D, et al. Lecithin increases plasma free choline and decreases hepatic steatosis in long-term total parenteral nutrition patients. Gastroenterology 1992;102:1363-70.
- Food and Nutrition Board, Institute of Medicine. Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline (2000). Washington, DC: National Academy Press, 2000. Available at: http://b
- Chatellier G, Lacomblez L. Tacrine (tetrahydroaminoacridine; THA) and lecithin in senile dementia of the Alzheimer type: a multicentre trial. Groupe Francais d'Etude de la Tetrahydroaminoacridine. BMJ 1990;300:495-9.
- Gelenberg AJ, Dorer DJ, Wojcik JD, et al. A crossover study of lecithin treatment of tardive dyskinesia. J Clin Psychiatry 1990;51:149-53.
- Little A, Levy R, Chuaqui-Kidd P, Hand D. A double-blind, placebo controlled trial of high-dose lecithin in Alzheimer's disease. J Neurol Neurosurg Psychiatry 1985;48:736-42. PubMed
- Palm M, Moneret-Vautrin DA, Kanny G, et al. Food allergy to egg and soy lecithins. Allergy 1999;54:1116-7. PubMed
- Drachman DA, Glosser G, Fleming P, et al. Memory decline in the aged: treatment with lecithin and physostigmine. Neurology 1982;32:944-50. PubMed
- Gelenberg, A. J., Doller-Wojcik, J. C., and Growdon, J. H. Choline and lecithin in the treatment of tardive dyskinesia: preliminary results from a pilot study. Am J Psychiatry 1979;136(6):772-776. PubMed
- Electronic Code of Federal Regulations. Title 21, Chapter 1, Subchapter B, Part 184: Direct food substances affirmed as Generally Recognized as Safe. Subpart B - listing of specific substances affirmed as GRAS. Sec. 184.1400 Lecithin. Available at: https:
Phosphatidylcholine 15 references
- Domino EF, May WW, Demetriou S, et al. Lack of clinically significant improvement of patients with tardive dyskinesia following phosphatidylcholine therapy. Biol Psychiatry 1985;20:1189-96. PubMed
- Aronson PJ, Lorincz AL. Promotion of palmar sweating with oral phosphatidylcholine. Acta Derm Venereol 1985;65:19-24. DOI
- Hexsel DM, Serra M, de Oliveira Dal'Forno T, et al. Cosmetic uses of injectable phosphatidylcholine on the face. Otolaryngol Clin North Am 2005;38:1119-29. PubMed
- Kopera D, Binder B, Toplak H, et al. Histopathologic changes after intralesional application of phosphatidylcholine for lipoma reduction: report of a case. Am J Dermatopathol 2006;28:331-3. PubMed
- Rittes PG. The use of phosphatidylcholine for correction of lower lid bulging due to prominent fat pads. Dermatol Surg 2001;27:391-2. PubMed
- Rotunda AM, Kolodney MS. Mesotherapy and phosphatidylcholine injections: historical clarification and review. Dermatol Surg 2006;32:465-80. PubMed
- Hexsel D, Serra M, Mazzuco R, et al. Phosphatidylcholine in the treatment of localized fat. J Drugs Dermatol 2003;2:511-8.
- Hasengschwandtner F. Phosphatidylcholine treatment to induce lipolysis. Cosmet Dermatol 2005;4:308-13. PubMed
- Rittes PG. The use of phosphatidylcholine for correction of localized fat deposits. Aesthetic Plast Surg 2003;27:315-8. PubMed
- Ablon G, Rotunda AM. Treatment of lower eyelid fat pads using phosphatidylcholine: clinical trial and review. Dermatol Surg 2004;30:422-7. PubMed
- Loguercio C, Andreone P, Brisc C, et al. Silybin combined with phosphatidylcholine and vitamin E in patients with nonalcoholic fatty liver disease: a randomized controlled trial. Free Radic Biol Med 2012;52(9):1658-65. PubMed
- Panos, J. M., Palson, R., Johnson, R., Portmann, B., and Williams, R. Polyunsaturated phosphatidylcholine for acute alcoholic hepatitis: a double blind randomized placebo controlled trial. Eur.J.Gastroenterol 1990;2:351-355.
- Stremmel W, Braun A, Hanemann A, Ehehalt R, Autschbach F, Karner M. Delayed release phosphatidylcholine in chronic-active ulcerative colitis: a randomized, double-blinded, dose finding study. J Clin Gastroenterol 2010;44(5):e101-7. PubMed
- Stremmel W, Ehehalt R, Autschbach F, Karner M. Phosphatidylcholine for steroid-refractory chronic ulcerative colitis: a randomized trial. Ann Intern Med. 2007;147(9):603-10. PubMed
- Stremmel W, Vural H, Evliyaoglu O, Weiskirchen R. Delayed Release Phosphatidylcholine is Effective for Treatment of Ulcerative Colitis: A Meta-Analysis. Dig Dis 2021;39(5):508-515. PubMed
Parts of this content are provided by the Therapeutic Research Center, LLC.
DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.
© 2021 Therapeutic Research Center, LLC